Loading…
India Infra Updates on WhatsApp
Join the Tenderkart WhatsApp channel for India Infra Updates
Loading…
Ref. No.
Eligibility, documents, scope and key termsEligibility, required documents, scope of work and key terms of this tender, in one click.
| # | Schedule | Awardee / L1 Bidder | Status | Bids | Value |
|---|---|---|---|---|---|
| 1 | Schedule 1 | Prathmesh Distributor | Awarded | 1 | ₹63,360 |
| 2 | Schedule 2 | VINDECA LIFE SCIENCES PRIVATE LIMITED | Awarded | 1 | ₹17,280 |
Tender Value
Refer Docs
EMD Value
Exempted
Closing Date
11 May 2024, 1:00 pmClosed
Eligibility, documents, scope and key termsEligibility, required documents, scope of work and key terms of this tender, in one click.
Magestrol Acetate 160mg tab (Q3)
Vilazodone 20mg tab (Q3)
6312926
GEM/2024/B/4861944
Two Packet Bid
Magestrol Acetate 160mg tab,Vilazodone 20mg tab
15 days
Delhi; New Delhi
Item wise evaluation
PRODUCT_CUSTOM
8 documents required · 8 mandatory
3 yrs
10%
| Item | Delivery Location | Qty | Delivery | Spec |
|---|---|---|---|---|
| Magestrol Acetate 160mg tab (Q3) | NEW DELHI | 1,920 | 15 days | - |
| Vilazodone 20mg tab (Q3) | NEW DELHI | 1,200 | 15 days |
Exempted
11 May 2024
15 Apr 2024
11 May 2024
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
bid_6312926.pdf
GEM_BID
echs_cfa_re-07_list_of_medicine_2024-04-15-12-14-22_b90be29b106a709fb11d0b825b0af05d.pdf
SPECIFICATION
echs_cfa_re-07_list_of_medicine_2024-04-15-12-17-45_320af065f3b1dfa4b7981f23909da735.pdf
SPECIFICATION
AtcDoc_1d957ef1-4714-4f63-aae11713165346380_soharabmudgil.500a@gov.in.pdf
OTHER
list-of-categories-where-trials-are-allowed_1712126171.pdf
OTHER
gtc.pdf
OTHER
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .